RCKT·77313F106·US·equity·Healthcare - Biotechnology-13D/G
RCKT (ROCKET PHARMACEUTICALS INC) is held by 106 institutional investors as of Q1 2026. Largest holders: RTW INVESTMENTS, LP ($63.3M), BlackRock, Inc. ($28M), CITIGROUP INC ($18.3M). Net institutional sentiment: Mixed.
See how RCKT's score breaks down across 4 SEC sources
Showing 1-20 of 123
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer